Contractor notice: Extension to SSPs for Fluoxetine 10mg tablets (SSP005) and Atorvastatin 10mg chewable tablets (SSP032)
The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Fluoxetine 10mg tablets (SSP005) and Lipitor® 10mg chewable tablets (SSP032). SSP005 for Fluoxetine 10mg tablets was due to expire on 12 August 2022 but the end date has been further extended to Wednesday 7 December 2022. [...]
The post Contractor notice: Extension to SSPs for Fluoxetine 10mg tablets (SSP005) and Atorvastatin 10mg chewable tablets (SSP032) appeared first on PSNC Website.
Recent Comments